Kidney Neoplasms
Conditions
Brief summary
Observational study, retrospective and prospective, of an analytical nature. Data will be collected from medical records and/or through contact with physicians and institutions (secondary data collection). Patients included retrospectively or prospectively will be followed during the data collection period for the evaluation of treatments and survival. No intervention is planned in this protocol.
Interventions
OTHERObservational study
This is an observational study; patients will not be exposed to clinical interventions different from those belonging to the standard of care.
Sponsors
Ipsen
Latin American Cooperative Oncology Group
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients ≥ 18 years of age; * Proven histology of renal cell carcinoma (any subtype); * Pathological diagnosis of renal cell carcinoma in January 2015 or later and new cases diagnosed during the period of recruitment of each center; * Have the medical record available and suitable for collecting data on patient characteristics, treatment and outcome.
Exclusion criteria
* Synchronous or other primary tumor within the last 3 years (except thyroid cancer or non melanoma skin).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Build a real-life renal cell cancer database in Brazil and Latin America | 2022 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clinicopathological characteristics of patients with renal cell cancer checklist | 2022 | date of onset of symptoms, pre-treatment symptoms, histology, clinical and pathological stage, performance status, tests used in staging, date of diagnosis, site of metastases, complications clinics. |
| Characteristics of systemic treatment checklist | 2022 | date of biopsy; dates, type and lines of drug treatment. |
| Time between diagnosis and start of treatment. | 2022 | Characteristics of systemic treatment checklist |
| Sociodemographic characteristics checklist | 2022 | Describe sociodemographic characteristics: age at diagnosis, race, education, family income, occupation, personal habits, family history, comorbidities, treatment funding (public or private), treatment institution (public, private or philanthropic). |
| Progression-free survival in each therapeutic line | 2022 | — |
| Overall survival | 2022 | — |
| Causes of delay or discontinuation of each treatment checklist | 2022 | Characteristics of systemic treatment |
Countries
Brazil
Outcome results
None listed